None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: a multi-center prospective cohort study. 1. Acute and subacute cerebral infarction (7 days -6month after stroke onset) 2. Age over 18 years 3. without AF on Admission ECG 4. at least 18-hours or more recording on 24-hour Holter monitoring 5. at least 72-hours or more recording on single lead wearable patch 6. Patients who can use a single-lead wearable patch device and related applications
Exclusion criteria
Exclusion criteria: 1. patients with known AF 2. Patient with valvular heart diseases related to AF (rheumatic mitral stenosis, a mechanical or bioprosthetic heart valve, or mitral valve repair, infective endocarditis) 3. Patients with underlying disease related to AF (binge drinking, recent cardiothoracic and noncardiac surgery (<2weeks), recent ST elevation myocardial infarction (MI) (<3month), pericarditis, myocarditis, hyperthyroidism, electrocution, pneumonia, and pulmonary embolism) 4. Patient with implanted pacemaker 5. LA enlargement =44mm 6. NT-proBNP (N-terminal pro-B-type natriuretic peptide) =1000 pg/mL 7. Patients with advanced systemic disease or coexisting neurological/psychiatric disease 8. Patients with contact dermatitis and other skin disorders 9. Patients who are unable to perform the study with other causes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection rate of Atrial Fibrillation | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence rates of stroke/TIA | — |
Countries
Korea, Republic of
Contacts
The Catholic University of Korea, Eunpyeong St. Mary's Hospital